Receptor agonists

Activate cellular receptors and elicit precise biological responses with our specialized range of potent and selective agonists. These compounds are part of our 2.7k+ biochemicals portfolio, validated by over 10.5k citations, and are engineered to provide reliable data for research into GPCR signaling, neurotransmission, and metabolic regulation.

Browse all agonists

button-secondary

What is an agonist?

Agonists mimic naturally occurring substances in the body by binding to specific receptors and inducing a biological response. This activation plays a significant role in studying downstream effects in various signaling pathways and understanding the intricacies of receptor dynamics, which are fundamental in disease models and several research areas, including neuroscience, metabolism, cardiovascular, and immunology.

What are receptor agonists?

Receptor agonists bind to receptors, influencing downstream processes influencing gene expression and playing pivotal roles in development, metabolism, and disease. Some signaling pathways may lead to changes in gene expression, depending on the receptor type.

Agonists vs antagonists

Agonists induce a biological response, while antagonists inhibit a biological response bind to receptors and block or reduce the effects of agonists without activating the receptor themselves.

Types of agonists

Full agonists

Full agonists bind to a receptor and produce the maximum possible biological response. They have high efficacy, meaning they can fully activate the receptor they bind to. For example, morphine is a full agonist at opioid receptors, producing strong analgesic effects.

Partial agonists

Partial agonists also bind to receptors but produce a partial response, even when all receptors are occupied. They have lower efficacy compared to full agonists. Partial agonists can act as functional antagonists in the presence of a full agonist by competing for receptor binding and reducing the overall response. An example is buprenorphine, which is a partial agonist at opioid receptors and is used in pain management and addiction treatment.

Inverse agonists

Inverse agonists are ligands that bind to the same receptor as agonists but induce the opposite effect by reducing the receptor's baseline activity. They actively suppress the receptor's intrinsic activity, leading to a decrease in downstream signaling. An example is naloxone at opioid receptors. While naloxone is commonly known as an antagonist used to reverse opioid overdoses, it also exhibits inverse agonist properties by reducing the basal activity of opioid receptors. Naloxone is primarily a competitive antagonist at opioid receptors, though it may exhibit weak inverse agonist activity under certain conditions.

Ion channel agonists

These compounds modulate ion channels, affecting the flow of ions across cellular membranes, which is crucial for several physiological functions, such as nerve and muscle function.

How to choose the right agonist

To choose the right agonist, you should consider:

Target specificity, potency, and selectivity
The compound’s receptor subtype affinity and its suitability for the intended application
Whether products are supported by validation through peer-reviewed citations

We offer a wide array of high-quality agonists, optimized for different receptor types, including ion channels and nuclear receptors. These agonists are meticulously validated for activity, purity, and stability, ensuring that researchers achieve consistent and reliable results. Our range of agonists can complement your experimental design, so you can progress with your research faster.